Carlota Aragon-De

Madrid, MD 28006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

Journal: Journal of personalized medicine

Published: March 25, 2026

Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification.

Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification.

Journal: International journal of molecular sciences

Published: January 27, 2026

Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome.

Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome.

Journal: JAAD international

Published: December 16, 2025

Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study.

Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study.

Journal: JAAD international

Published: November 09, 2025

Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial.

Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial.

Journal: JAMA dermatology

Published: September 24, 2025

Bimekizumab as-needed dosing in patients with psoriasis: a case series.

Bimekizumab as-needed dosing in patients with psoriasis: a case series.

Journal: The Journal of dermatological treatment

Published: April 21, 2025

Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis.

Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis.

Journal: The Journal of dermatological treatment

Published: April 08, 2025

Subclinical atherosclerosis is increased in moderate-to-severe atopic dermatitis.

Subclinical atherosclerosis is increased in moderate-to-severe atopic dermatitis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 26, 2024

Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.

Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.

Journal: The Journal of investigative dermatology

Published: November 21, 2024

Impact of the Mediterranean Diet on Patients With Psoriasis: Protocol for a Randomized Controlled Trial.

Impact of the Mediterranean Diet on Patients With Psoriasis: Protocol for a Randomized Controlled Trial.

Journal: JMIR research protocols

Published: July 13, 2024

Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters.

Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters.

Journal: Journal of clinical medicine

Published: May 20, 2024

Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab.

Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab.

Journal: International journal of dermatology

Published: January 03, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026